Amy Dockser Marcus is a health and science reporter for The Wall Street Journal in Boston.

The FDA has approved Otarmeni, the first gene therapy for genetic hearing loss, through its National Priority Voucher program ...

Researchers have used modified CRISPR to silence the extra chromosome 21 in Down syndrome cells, showing promising ...

Genome editing is revolutionizing the medical landscape by offering new therapeutic possibilities for genetic diseases, which collectively affect hundreds ...

The U.S. Food and Drug Administration today approved Otarmeni (lunsotogene parvec-cwha), the first-ever dual adeno-associated virus (AAV) vector-based gene therapy. Otarmeni is indicated for the ...

Charles Gersbach and his colleagues are pursuing promising CRISPR technologies focused on controlling gene activity rather ...

Roizman reshaped the field of virology through his work on the herpes simplex virus, laying the groundwork for efforts to ...

The U.S. Food and Drug Administration has approved Regeneron's gene therapy ‌for a rare genetic form of deafness, the company ...

Greater childhood intake of ultra-processed foods was associated with higher body mass index in young adulthood. 2. The ...

Abnormalities in DNA methylation, a genetic modification, may affect disease risk in idiopathic pulmonary fibrosis, according ...

Flagship Pioneering Inc. has announced the launch of Serif Biomedicines Inc., a biotechnology company pioneering modified DNA ...

The startup is developing “modified DNA” therapies it claims can combine the strengths of multiple approaches, from messenger ...